[Federal Register Volume 87, Number 20 (Monday, January 31, 2022)]
[Notices]
[Pages 4943-4944]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01817]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-946]


Importer of Controlled Substances Application: Mylan 
Pharmaceuticals Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Mylan Pharmaceuticals Inc. has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before March 2, 2022. 
Such persons may also file a written request for a hearing on the 
application on or before March 2, 2022.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield,

[[Page 4944]]

Virginia 22152. All request for a hearing should also be sent to: (1) 
Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 
Morrissette Drive, Springfield, Virginia 22152; and (2) Drug 
Enforcement Administration, Attn: DEA Federal Register Representative/
DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on December 7, 2021, Mylan Pharmaceuticals Inc., 2898 
Manufacturers Road, Greensboro, North Carolina 27406-4600, applied to 
be registered as an importer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                            Drug
          Controlled substance              code          Schedule
------------------------------------------------------------------------
Remifentanil............................     9739  II
------------------------------------------------------------------------

    The company plans to import the above controlled substance as a 
Federal Drug Administration-approved drug product in finished dosage 
form for commercial distribution to its customers.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2).

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2022-01817 Filed 1-28-22; 8:45 am]
BILLING CODE 4410-09-P